| Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study (NCT01634477) | Thai Red Cross AIDS Research Centre | 2010-01-01 |
| IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women (NCT00955968) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2010-01-01 |
| Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects (NCT00991289) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-01 |
| The Impact of Omega Three Fatty Acids on Vascular Function in HIV (NCT01041521) | Tufts University | 2010-01-01 |
| PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen (NCT01190293) | St Stephens Aids Trust | 2010-01-01 |
| Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy (NCT01606722) | Hospitales Universitarios Virgen del Rocío | 2010-01-01 |
| Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer (NCT00968630) | Fred Hutchinson Cancer Center | 2009-12-17 |
| Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients (NCT01044654) | Sangamo Therapeutics | 2009-12-01 |
| Study of Bone Disease in Older HIV-infected Adults (NCT00935935) | Ruth M. Rothstein CORE Center | 2009-12-01 |
| Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers (NCT00880698) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-12-01 |
| Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents (NCT00921557) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-01 |
| Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir (NCT00976404) | Robert L. Murphy | 2009-11-01 |
| Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients (NCT01022905) | University Hospital, Geneva | 2009-11-01 |
| Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4 (NCT01006031) | Sociedad Andaluza de Enfermedades Infecciosas | 2009-10-01 |
| A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa (NCT00931346) | International AIDS Vaccine Initiative | 2009-10-01 |
| ADHEPTA Study: Adherence Questionnaire in Hepatitis C (NCT00998621) | Fundacion IMIM | 2009-10-01 |
| Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts (NCT00951795) | Abbott RDx Cardiometabolic | 2009-09-01 |
| Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration (NCT00944541) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-09-01 |
| Cardiovascular Prevention for Persons With HIV (NCT00982189) | Hennepin Healthcare Research Institute | 2009-09-01 |
| Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects (NCT01010399) | Felizarta, Franco, M.D. | 2009-09-01 |
| Integration of Family Planning and HIV Services in Tanzania (NCT00941876) | FHI 360 | 2009-08-01 |
| Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy (NCT00890747) | National Cancer Institute (NCI) | 2009-08-01 |
| Preparing for Adolescent HIV Vaccine Trials in South Africa: (NCT00944879) | Desmond Tutu HIV Centre | 2009-08-01 |
| Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients (NCT00943540) | Radboud University Medical Center | 2009-07-01 |
| Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters (NCT00851799) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-06-01 |
| A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients (NCT00903682) | Janssen-Cilag International NV | 2009-06-01 |
| Profile of HIV Seropositive Patients (NCT00981279) | Universidade Federal de Goias | 2009-06-01 |
| Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-infected Patients (NCT01392430) | Chiang Mai University | 2009-06-01 |
| Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People (NCT00919724) | Indiana University | 2009-05-01 |
| Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia (NCT00797381) | Shanghai Public Health Clinical Center | 2009-05-01 |
| Comparative Study of Three NNRTI-Sparing HAART Regimens (NCT00811954) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2009-05-01 |
| Strategic Timing of Antiretroviral Treatment (NCT00867048) | University of Minnesota | 2009-04-15 |
| Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC) (NCT00918840) | Genetic Immunity | 2009-04-01 |
| Buprenorphine/Raltegravir Pharmacokinetic Interaction Study (NCT00858962) | Yale University | 2009-03-01 |
| HIV Treatment and CVD Events (NCT01054638) | ViiV Healthcare | 2009-03-01 |
| Stocrin Re-examination Study (0831-028) (NCT01065792) | Merck Sharp & Dohme LLC | 2009-03-01 |
| Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection (NCT01065207) | French National Agency for Research on AIDS and Viral Hepatitis | 2009-03-01 |
| Raltegravir Activity In Lymphoid Tissues (NCT00863668) | University of Minnesota | 2009-03-01 |
| Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 Study (NCT01669954) | King's College London | 2009-02-01 |
| Micronutrients and Antioxidants in HIV Infection (NCT00798772) | Ottawa Hospital Research Institute | 2009-01-01 |
| Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir (NCT00817765) | Radboud University Medical Center | 2009-01-01 |
| Pharmacotherapy for HIV Infected Patients With Alcohol Problems (NCT00854230) | VA Connecticut Healthcare System | 2009-01-01 |
| Effect of Raltegravir on Endothelial Function in HIV-Infected Patients (NCT00843713) | University of California, San Francisco | 2009-01-01 |
| Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC (NCT00865475) | Fundacion SEIMC-GESIDA | 2008-12-01 |
| Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy (NCT00865007) | Fundacion SEIMC-GESIDA | 2008-12-01 |
| Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials (NCT00789789) | ANRS, Emerging Infectious Diseases | 2008-12-01 |
| An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin (NCT00771498) | Oswaldo Cruz Foundation | 2008-11-01 |
| Community-based Evaluation of a Pilot PMTCT Project in Kafue District (NCT00753428) | University of North Carolina, Chapel Hill | 2008-11-01 |
| Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT) (NCT01230580) | Medical Research Council | 2008-11-01 |
| Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM) (NCT01327898) | Nova Southeastern University | 2008-11-01 |
| Aspirin and Antiretroviral Therapy in HIV Infected Patients (NCT00783614) | Hennepin Healthcare Research Institute | 2008-10-01 |
| Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure (NCT00735072) | University of California, San Francisco | 2008-09-01 |
| A Trial to Determine the Long-term Durability of Virologic Suppression in Kaletra Recipients With Imperfect Adherence (NCT00785616) | Montefiore Medical Center | 2008-09-01 |
| PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV Infection (NCT00775424) | University of Pennsylvania | 2008-09-01 |
| Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study (NCT01038401) | ANRS, Emerging Infectious Diseases | 2008-09-01 |
| Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir (NCT00708162) | Gilead Sciences | 2008-07-01 |
| Safety and Efficacy Study of Switching From Epzicom to Truvada (NCT00724711) | Gilead Sciences | 2008-07-01 |
| Human Immunodeficiency Virus (HIV), Arterial Dysfunction, Lipids, Lovaza (HALO) Trial (NCT00795717) | Tufts University | 2008-07-01 |
| Cohort of HIV Associated Lymphomas (NCT01164436) | ANRS, Emerging Infectious Diseases | 2008-06-01 |
| Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal. (NCT00812318) | ViiV Healthcare | 2008-06-01 |
| Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures (NCT00678587) | GlaxoSmithKline | 2008-06-01 |
| Pilot Trial of a Synbiotic in HIV+ Patients (NCT00688311) | University of California, Davis | 2008-05-01 |
| Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST) (NCT00670839) | ANRS, Emerging Infectious Diseases | 2008-05-01 |
| Raltegravir in the Swiss HIV Cohort Study (NCT00904644) | University of Zurich | 2008-04-01 |
| Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients (NCT00711230) | Genetic Immunity | 2008-04-01 |
| QoL and Adherence to One-pill Once-a-day HAART (NCT00990600) | A.O. Ospedale Papa Giovanni XXIII | 2008-04-01 |
| Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs) (NCT01103596) | Abbott | 2008-03-01 |
| Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects (NCT01024556) | Barbara Ensoli, MD | 2008-03-01 |
| Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women (NCT00710593) | University of North Carolina, Chapel Hill | 2008-02-01 |
| A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744 (NCT00659191) | GlaxoSmithKline | 2008-02-01 |
| Pharmacokinetic Study on Raltegravir and Lamotrigine (NCT00618241) | Radboud University Medical Center | 2008-02-01 |
| Postprandial Endothelial Dysfunction After a High-Fat Meal in HIV-infected Men (NCT00846599) | Tufts University | 2008-01-01 |
| Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV (NCT00527618) | University of Washington | 2007-12-01 |
| Reassessment of the Nutritional Status in Thai Orphans Living With HIV in a Family Style Community (NCT01002612) | Thai Red Cross AIDS Research Centre | 2007-12-01 |
| Efficacy and Safety of Single Versus Double Ritonavir-boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens (NCT00886990) | The HIV Netherlands Australia Thailand Research Collaboration | 2007-10-01 |
| Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia (NCT00618371) | University of Pittsburgh | 2007-10-01 |
| Observational Study of the Therapeutic Study of Recombinant HIV-1 TAT (NCT01024595) | Istituto Superiore di Sanità | 2007-09-01 |
| Multicenter, Safety Study Of Maraviroc (NCT00478231) | ViiV Healthcare | 2007-07-01 |
| KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects (NCT00549198) | GlaxoSmithKline | 2007-06-01 |
| Cognitive Behavioral Therapy to Help HIV Infected Adults With Depression to Adhere to Antiretroviral Therapy (NCT00509340) | RAND | 2007-06-01 |
| Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701 In HIV-1 Infected Patients (NCT00481390) | GlaxoSmithKline | 2007-06-01 |
| MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED) (NCT00443729) | Merck Sharp & Dohme LLC | 2007-05-01 |
| Using Multimedia Technologies to Disseminate an HIV Prevention (NCT01863537) | Columbia University | 2007-05-01 |
| Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients (NCT00420355) | University of Oklahoma | 2007-04-01 |
| A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701 (NCT00435838) | GlaxoSmithKline | 2007-03-01 |
| Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection (NCT00440947) | ViiV Healthcare | 2007-03-01 |
| Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects (NCT02191657) | ApoPharma | 2006-11-01 |
| Development of Serologic Assays for Human Herpes Virus-8 (NCT00395278) | National Institutes of Health Clinical Center (CC) | 2006-10-30 |
| Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA) (NCT00334256) | French National Agency for Research on AIDS and Viral Hepatitis | 2006-10-01 |
| A Study To Evaluate Formulations And Food Effect On GSK364735 In Healthy Subjects. (NCT00386347) | GlaxoSmithKline | 2006-10-01 |
| Study of the Effectiveness of Passive Immunotherapy in HIV-Infected Patients Who Are in Virologic Failure (NCT00353327) | Hospital Clinic of Barcelona | 2006-10-01 |
| Testing an HIV Prevention Intervention for Psychiatric Patients in Brazil (NCT00881699) | New York State Psychiatric Institute | 2006-09-01 |
| Pharmacokinetics and Pharmacodynamics of an Anti-HIV Drug in Israeli Ethiopian and Non-Ethiopian Populations (NCT00347750) | Rambam Health Care Campus | 2006-09-01 |
| Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand (NCT00197639) | Harvard School of Public Health (HSPH) | 2006-09-01 |
| A Long Term, Safety Study of Apricitabine in HIV-infected Subjects (NCT00367952) | Avexa | 2006-08-01 |
| HLA-B*5701 And Hypersensitivity To Abacavir (NCT00373945) | GlaxoSmithKline | 2006-08-01 |
| Buprenorphine HIV Care Integration Project (NCT00348868) | University of Miami | 2006-07-01 |
| PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months (NCT01973439) | PENTA Foundation | 2006-07-01 |
| Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together (NCT00352066) | Avexa | 2006-07-01 |
| Cardiovascular Risk Factor Management in HIV Infection (NCT00264394) | University Hospital, Basel, Switzerland | 2006-07-01 |